Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Beyond the joints, TNFi (tumour necrosis factor inhibitor) therapy may confer systemic benefits in rheumatoid arthritis (RA). Several studies have investigated the role of TNFi on insulin resistance/sensitivity (IR/IS). This question is of general interest given the emerging evidence linking inflammation and insulin resistance. The main aim of this review was to summarise the published data and to determine the effects of TNFi on IR/IS. METHODS: We searched the PubMed and ISI Web of Knowledge databases for studies which examined the effects of TNFi on IR/IS. The studies were assessed independently by two reviewers according to a pre-specified protocol. The data on Homeostatic Model Assessment for Insulin resistance (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI) were pooled and reported as standard difference in means (SDM) with 95% confidence interval (CI) using a random-effects model. RESULTS: A total of eight studies with 260 subjects met the selection criteria. The duration of the studies was from 8 weeks to 12 months. There was statistically significant reduction in HOMA index in six out of eight studies and four reported significant increment in QUICKI. The pooled analysis revealed significant reduction in HOMA [SDM-0.148, 95%CI[-0.278 to -0.017], p=0.026] and increment in QUICKI [SDM 0.312, 95%CI[0.019 to 0.606], p=0.037] with TNFi. CONCLUSION: There is emerging evidence to support that TNFi therapy improves IS and reduces IR in RA. Further, well conducted trials are needed to determine if such effects translate to lower incidence of diabetes in RA or other autoimmune conditions on biologic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent meta-analysis of eight RCTs that included a total of 260 participants, anti-TNF-α inhibitor therapy was found to significantly reduce insulin resistance in patients with rheumatoid arthritis and to improve their insulin sensitivity42.”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“The QUICKI, on the other hand, measures IS using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose [13].”
MethodHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Lumeij, J. T. (1997) · Clinical Biochemistry of Domestic Animals · doi:10.1016/b978-012396305-5/50031-2 · Cited by 1,163
Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., & Taylor, R. (1996) · Diabetes · doi:10.2337/diab.45.7.881 · Cited by 510 · cited 1×
“[37] reported that the fasting glucose, fasting insulin and C-peptide levels were unaffected by TNFi therapy in obese Type 2 diabetics.”
BackgroundTurner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388 · cited 1×
“The HOMA was developed from physiological studies into mathematical equations describing glucose regulation by estimating insulin resistance and β-cell function from fasting glucose and insulin levels [12].”
Method
Research works printed but not linked: 3
- Oguz FM, Oguz A, Uzunlulu M. The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis. Acta Clin Belg. 2007 Jul-Aug; 62(4): 218– 22. 17849692 · DOI
- Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis. 2005 5; 64(5): 765– 6. 15458960 PMC1755470 · DOI · Paper page
- Ferraz-Amaro I, Arce-Franco M, Muñiz J, López-Fernández J, Hernández-Hernández V, Franco A, et al Systemic Blockade of TNF-α does not Improve Insulin Resistance in Humans. Horm Metab Res.2011 18 10 2011; 43(11): 801– 8. 10.1055/s-0031-1287783 22009376 · DOI · Paper page
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Obesity and Cancer: The Oil that Feeds the Flame
Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 356
“Similar observations were made on the degree of IR in RA patients on anti-TNF therapy (Burska et al., 2015; Solomon et al., 2011).”
Chronic tissue inflammation and metabolic disease
Lee, Y. S., & Olefsky, J. (2021) · Genes & Development · doi:10.1101/gad.346312.120 · Cited by 335
“Perhaps the most promising findings are from a meta-analysis study showing that TNF-α antibody treatment might reduce the risk of developing T2DM (Burska et al. 2015), although, again, this would have to be demonstrated in a prospective study for translational validation.”
BackgroundMacrophages, Chronic Inflammation, and Insulin Resistance
Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., & Zheng, W. (2022) · Cells · doi:10.3390/cells11193001 · Cited by 264
“concluded that TNF-α inhibitor treatment improves insulin sensitivity in rheumatoid arthritis (RA) patients [228].”
BackgroundSystemic inflammation after stroke: implications for post‐stroke comorbidities
Simats, A., & Liesz, A. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216269 · Cited by 276
Cytokine Signaling in Skeletal Muscle Wasting
Zhou, J., Liu, B., Liang, C., Li, Y., & Song, Y.-H. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.03.002 · Cited by 172
“A meta-analysis of eight studies with 260 subjects revealed that TNF-/ inhibitor therapy reduces insulin resistance in RA [65].”
BackgroundMethodImpact of the treatment of periodontitis on systemic health and quality of life: A systematic review
Orlandi, M., Aguilera, E. M., Marletta, D., Petrie, A., Suvan, J. E., & D’Aiuto, F. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13554 · Cited by 155
Metabolic syndrome, autoimmunity and rheumatic diseases
Medina, G., Lastra, O. L. V., Peralta-Amaro, A. L., Jiménez-Arellano, M. P., Saavedra, M. Á., Cruz-Domínguez, M. P., & Jara, L. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.009 · Cited by 143
“In act, it has been reported that the therapeutic blockade of TNFmproves insulin sensitivity and reduces IR in RA patients [56].”
Type 2 Diabetes: How Much of an Autoimmune Disease?
de Candia, P., Prattichizzo, F., Garavelli, S., Rosa, V. D., Galgani, M., Rella, F. D., Spagnuolo, M. I., Colamatteo, A., Fusco, C., Micillo, T., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00451 · Cited by 130
Wagenaar, C. A., van de Put, M., Bisschops, M., Walrabenstein, W., de Jonge, C. S., Herrema, H., & van Schaardenburg, D. (2021) · Nutrients · doi:10.3390/nu13093208 · Cited by 131
“Consequently, reducing inflammation leads to a reduction of cardiovascular events and its risk factors [7,8].”
BackgroundAnti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Kuryłowicz, A., & Koźniewski, K. (2020) · Molecules · doi:10.3390/molecules25092224 · Cited by 99
Targeting Inflammatory Cytokines to Improve Type 2 Diabetes Control
Velikova, T. V., Kabakchieva, P., Assyov, Y. S., & Georgiev, T. (2021) · BioMed Research International · doi:10.1155/2021/7297419 · Cited by 95
“A meta-analysis of eight studies involving 260 subjects has shown that TNF-α inhibition leads to a significant reduction in HOMA (Homeostatic Model Assessment for Insulin resistance) and QUICKI (Quantitative Insulin Sensitivity Check Index) indices, which are surrogate markers for IR [84].”
BackgroundMethodManaging the Patient with Psoriasis and Metabolic Comorbidities
Bellinato, F., Maurelli, M., Geat, D., Girolomoni, G., & Gisondi, P. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00857-0 · Cited by 90
Moshapa, F. T., Riches‐Suman, K., & Palmer, T. M. (2019) · Cardiology Research and Practice · doi:10.1155/2019/9846312 · Cited by 79
“/ere is also growing evidence that anti-TNF-α biological drugs used to treat rheumatoid arthritis (RA) can improve insulin sensitivity and reduce insulin resistance in RA patients, raising the possibility that targeting proinflammatory pathways may also have therapeutic benefits in T2DM patients [49].”
Villarreal-Calderón, J. R., Cuellar-Támez, R. X., Ramos-González, M. R., Rubio‐Infante, N., Castillo, E. C., Elizondo‐Montemayor, L., & García‐Rivas, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3940739 · Cited by 69
“Furthermore, anti-TNF-α treatment has been able to reduce insulin resistance in rheumatoid arthritis [46] and in psoriasis [47].”
BackgroundBiomarkers of non-communicable chronic disease: an update on contemporary methods
Al‐Hadlaq, S. M., Balto, H. A. G., Hassan, W. M., Marraiki, N., & El-Ansary, A. K. (2022) · PeerJ · doi:10.7717/peerj.12977 · Cited by 58
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do
Szekanecz, Z., Kerekes, G., Végh, E., Kardos, Z., Baráth, Z., Tamási, L., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.014 · Cited by 58
Ruscitti, P., Ursini, F., Cipriani, P., Greco, M., Alvaro, S., Vasiliki, L., Benedetto, P. D., Carubbi, F., Berardicurti, O., Gulletta, E., et al. (2019) · Medicine · doi:10.1097/md.0000000000014587 · Cited by 53
“Unfortunately, the results of these meta-analysis need to be cautiously interpreted due to the high heterogeneity and the presence of established diabetes in exclusion criteria in some of included studies.([28,29]) In this context, although we have patients in a relative early stage of diabetes and further studies are…”
ResultInsulin Signaling in Arthritis
Tripolino, C., Ciaffi, J., Pucino, V., Ruscitti, P., van Leeuwen, N., Borghi, C., Giacomelli, R., Meliconi, R., & Ursini, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672519 · Cited by 46
van den Oever, I. A., Baniaamam, M., Şimşek, S., Raterman, H. G., van Denderen, J. C., van Eijk, I. C., Peters, M. J. L., van der Horst-Bruinsma, I. E., Smulders, Y. M., & Nurmohamed, M. T. (2020) · Rheumatology International · doi:10.1007/s00296-020-04666-6 · Cited by 42
“Nonetheless, as several studies did observe similar effects after comparable treatment period [14, 32], this did not hamper the assessment of the relation between systemic inflammation and insulin resistance.”
BackgroundResultPaschou, S. Α., Kothonas, F., Lafkas, A., Myroforidis, A., Loi, V., Terzi, T., Karagianni, O., Poulou, A., Goumas, K., & Vryonidou, A. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6712901 · Cited by 40
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
Rybtsova, N., Berezina, T. N., Kagansky, A., & Александрович, Р. С. (2020) · Biomedicines · doi:10.3390/biomedicines8120615 · Cited by 36
Mohamed, H. E., Asker, M. E.-S., Keshawy, M. M., Hasan, R. A., & Mahmoud, Y. K. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03686-x · Cited by 34
Zhou, Y., Liu, L., Xiang, R., Bu, X., Qin, G., Dai, J., Zhao, Z., Fang, X., Yang, S., Han, J. H., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109529 · Cited by 34
Bissell, L.-A., Hensor, E. M. A., Kozera, Ł., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H. I., Villeneuve, É., Donica, H., Buch, M. H., et al. (2016) · Rheumatology · doi:10.1093/rheumatology/kew306 · Cited by 31
Self-citationSphingosine 1-Phosphate Regulates Obesity and Glucose Homeostasis
Kajita, K., Ishii, I., Mori, I., Asano, M., Fuwa, M., & Morita, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020932 · Cited by 33
“In clinical trials using TNF α -targeted drugs that are effective against rheumatoid arthritis, a few were slightly effective in improving insulin sensitivity [60], while others were not [61,62].”
Incretins in patients with rheumatoid arthritis
Segura, B. T., López‐Mejías, R., Domínguez‐Luis, M. J., de Vera-González, A. M., Delgado, A. G., Ubilla, B., Olmos, J. M., Hernández, J. L., González-Gay, M. Á., & Ferraz‐Amaro, I. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1431-9 · Cited by 29
“In addition, anti-TNF-α therapy has been shown to improve insulin sensitivity and reduce IR in RA [11].”
BackgroundNon-alcoholic Fatty liver Disease in Patients with Psoriasis - Therapeutic Implications
Kłujszo, E. H., Parcheta, P., Witkowska, A. B., & Kręcisz, B. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2019.83983 · Cited by 27
Anti-TNF-α antibody alleviates insulin resistance in rats with sepsis-induced stress hyperglycemia
Qu, W., Han, C., Li, M., Zhang, J., & Jiang, Z. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0742-7 · Cited by 28
Ursini, F., Russo, E., Ruscitti, P., Giacomelli, R., & Sarro, G. D. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.030 · Cited by 26
Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association
Muzio, C. D., Cipriani, P., & Ruscitti, P. (2022) · BioDrugs · doi:10.1007/s40259-022-00561-7 · Cited by 28
Rochette, E., Saidi, O., Merlin, É., & Duché, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1119930 · Cited by 29
Angiopoietin-like 4: A molecular link between insulin resistance and rheumatoid arthritis
Masuko, K. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23507 · Cited by 35
“Thus, both metabolic comorbidity and joint destruction coincide in RA, so PPAR and/or ANGPTL4, but particularly the secretary protein ANGPTL4, may be considered as potential therapeutic targets for combating RA.”
BackgroundInfluentialInflammation and insulin resistance: New targets encourage new thinking
Johnson, A. M. F., Hou, S., & Li, P. (2017) · BioEssays · doi:10.1002/bies.201700036 · Cited by 24
MLKL deficiency protects against low-grade, sterile inflammation in aged mice
Crutchfield, E. C. T., Garnish, S. E., Day, J. A., Anderton, H., Chiou, S., Hempel, A., Hall, C. M., Patel, K. M., Gangatirkar, P., Martin, K., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01121-4 · Cited by 25
Metabolic abnormalities in patients with inflammatory rheumatic diseases
Dessein, P. H., Solomon, A., & Hollan, I. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.001 · Cited by 25
Lim, W. S., Teoh, S. E., Tang, A. S. P., Tan, B. J. M., Lee, J. Y., Yau, C. E., Thumboo, J., & Ng, Q. X. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103001 · Cited by 24
Méndez-García, L. A., Trejo‐Millán, F., Martínez‐Reyes, C. P., Manjarrez‐Reyna, A. N., Esquivel‐Velázquez, M., Meléndez, G., Islas‐Andrade, S., Rojas‐Bernabé, A., Kzhyshkowska, J. G., & Escobedo, G. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12716 · Cited by 24
“In this sense, rheumatoid arthritis patients receiving infliximab show decreased values of the homeostatic model assessment of insulin resistance (HOMA‐IR) as well as increase in the quantitative insulin sensitivity check index (QUICKI).(24) Similarly, non‐diabetic patients with ankylosing spondylitis also exhibit red…”
BackgroundMerola, J. F., Kavanaugh, A., Lebwohl, M., Gniadecki, R., & Wu, J. J. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00790-2 · Cited by 20
Cardiovascular Consequences of Autoimmune Rheumatic Diseases
Atzeni, F., Nucera, V., Gerratana, E., Fiorenza, A., Gianturco, L., Corda, M., & Sarzi‐Puttini, P. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200127142936 · Cited by 21
Exercise-induced inflammatory and metabolic adaptations in ageing: A meta-analytic compendium
Sheldon, R., Gan, A., Tasong, J., Yap, A., Ahmad, M., Júnior, P. R. H., Viswanathan, K., Setti, N. S. M., Jarman, O., Hoque-Uddin, S., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102974 · Cited by 17
Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA)
Kattamuri, L. P. V., Duggal, S., Aparece, J. P., & Sairam, S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02198-8 · Cited by 18
Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis
Ristić, G. G., Subota, V., Stanisavljevic, D. M., Vojvodić, D., Ristić, A. D., Glišić, B., Petronijević, M., & Stefanović, D. Z. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02476-0 · Cited by 17
“The significance of inflammation and disease activity control is also reflected through the influence of antiinflammatory therapy which improves insulin sensitivity in RA patients [44, 45].”
BackgroundAvouac, J., Ait‐Oufella, H., Habauzit, C., Benkhalifa, S., & Combe, B. G. (2025) · Rheumatology and Therapy · doi:10.1007/s40744-025-00753-x · Cited by 16
“Inflammatory arthritis is associated with insu‑ lin resistance [140], but treatment with biologi‑ cal agents reduces insulin resistance [141, 142].”
Cardiorespiratory fitness, white blood cell count, and mortality in men and women
Farrell, S. W., Leonard, D. S., Shuval, K., DeFina, L. F., Barlow, C. E., Pavlovic, A., & Haskell, W. L. (2021) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2021.10.005 · Cited by 14
“For example, a 2015 meta-analysis of 8 RCTs using antitumor necrosis factor-a therapy showed that reduction of antitumor necrosis factor-a was significantly associated with increased insulin sensitivity and decreased risk of developing Alzheimer’s disease in patients with rheumatoid arthritis.(54) Results from a doubl…”
Qian, Y., Mao, M., & Nian, F. (2022) · Cardiology Research and Practice · doi:10.1155/2022/6192053 · Cited by 15
“Insulin resistance increases in patients with RA and is associated with accelerated coronary atherosclerosis [131], and TNF-α antagonists have been shown to improve insulin sensitivity and reduce insulin resistance in patients with RA [132].”
BackgroundStrand, K., Stiglund, N., Haugstøyl, M. E., Kamyab, Z., Langhelle, V., Lawrence‐Archer, L., Busch, C., Cornillet, M., Hjellestad, I. D., Nielsen, H. J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.856530 · Cited by 16
Liñares, A., Dopico, J., Blanco, C., Pico, A., Sobrino, T., Blanco, J., & Leira, Y. (2024) · Clinical Oral Implants Research · doi:10.1111/clr.14339 · Cited by 11
Chi, P., Wu, K.-T., Chen, P., Chen, C. O., Su, Y., Yang, C., & Chen, J. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.939857 · Cited by 13
Kragsnæs, M. S., Blanco, J. M., Mullish, B. H., Serrano-Contreras, J. I., Kjeldsen, J., Horn, H. C., Stengaard‐Pedersen, K., Munk, H. L., Nilsson, A. C., Salam, A., et al. (2023) · ACR Open Rheumatology · doi:10.1002/acr2.11604 · Cited by 11
“Both treatment with MTX and TNFi have previously been linked to improved insulin sensitivity (45,46).”
BackgroundUseful message in choosing optimal biological agents for patients with autoimmune arthritis
Lai, J.-H., Ling, X. C., & Ho, L. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.007 · Cited by 11
Carneiro, A. D. A., Sinoti, S. B. P., de Freitas, M. M., Simeoni, L. A., Fagg, C. W., Magalhães, P. O., Silveira, D., & Fonseca-Bazzo, Y. M. (2022) · Plants · doi:10.3390/plants11223147 · Cited by 14
“Furthermore, the inhibition of inflammation has been shown to be beneficial in managing these diseases [7,8].”
BackgroundMohamad, H. E., Asker, M. E.-S., Keshawy, M. M., Aal, S. M. A., & Mahmoud, Y. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172959 · Cited by 11
Research on the anti-ageing mechanism of Prunella vulgaris L.
Li, P., Lv, X., Wang, J., Zhang, C., Zhao, J., & Yang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-39609-1 · Cited by 10
“According to Burska et al. 10 , the anti-TNF-α antibodies can considerably lower insulin resistance and improve insulin sensitivity in patients with rheumatoid arthritis (RA).”
Chen, Y., Chen, P., Chang, C., Lin, C., Chen, H., Lan, J., Chang, S., & Chen, D. (2020) · Life · doi:10.3390/life10120330 · Cited by 9
“Moreover, lipid profiles and CVD risks may have changed following conventional synthetic (cs)DMARDs and biological therapy [58,59].”
BackgroundNew Possibilities to Reduce the Residual Risk in Patients with Ischemic Heart Disease
Bershtein, L. L. (2020) · Kardiologiia · doi:10.18087/cardio.2020.11.n1370 · Cited by 9
Rochette, E., Bourdier, P., Pereira, B., Doré, É., Birat, A., Ratel, S., Echaubard, S., Duché, P., & Merlin, É. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-019-0354-1 · Cited by 9
Fousekis, F. S., Lamprou, A., Saridi, M. I., Mastorogianni, I. N., Mpakogiannis, K. C., Lianos, G. D., & Katsanos, K. H. (2026) · Metabolites · doi:10.3390/metabo16030181 · Cited by 9
Rolle der Metaflammation als systemische Manifestation bei Stoffwechselerkrankungen
Schäffler, A. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01416-7 · Cited by 11
Bellan, M., Bor, S., Gibbin, A., Gualerzi, A., Favretto, S., Guaschino, G., Bonometti, R., Rossini, A., Sola, D., Pedrazzoli, R., et al. (2018) · Reumatismo · doi:10.4081/reumatismo.2018.1061 · Cited by 6
Nyambuya, T. M., Dludla, P. V., & Nkambule, B. B. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104313 · Cited by 6
Sellam, J., Morel, J., Tournadre, A., Bouhnik, Y., Cornec, D., Devauchelle‐Pensec, V., Dieudé, P., Goupille, P., Jullien, D., Kluger, N., et al. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105174 · Cited by 5
Role of L-carnitine in exercise training: Anti-inflammatory, antioxidant, and metabolic interactions
Aminizadeh, S., Zarezadehmehrizi, A., Deh-Ahmadi, M. A., & Shahouzehi, B. (2025) · Advances in Redox Research · doi:10.1016/j.arres.2025.100149 · Cited by 4
Influence des traitements sur le risque cardiovasculaire de la polyarthrite rhumatoïde
Soubrier, M., Castagné, B., Tatar, Z., & Tournadre, A. (2017) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2017.11.002 · Cited by 4
Martel, C., Mamedova, L. K., Minton, J. E., García, M., Legallet, C., & Bradford, B. J. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0224-y · Cited by 3
“Furthermore, a recent review [42] concluded that the therapeutic use of TNFα inhibitors improves insulin sensitivity in patients with rheumatoid arthritis.”
BackgroundDhanush, Y., & Ganesh, V. S. (2026) · Inflammopharmacology · doi:10.1007/s10787-025-02104-2 · Cited by 4
“In patients with rheuma - toid arthritis, anti-TNF-α treatment significantly reduced insulin resistance and raised insulin sensitivity, according to a recent meta-analysis of eight RCTs with 260 volunteers (Burska et al. 2015).”
COMORBIDADES ENTRE PACIENTES COM ARTRITE REUMATOIDE E SUA ASSOCIAÇÃO COM A DESCOMPENSAÇÃO CLÍNICA
Fernandes, A. C. D. C., Gonçalves, T. S., Silva, H. M., Neves, C. D. M., Oliveira, I. V., de Oliveira, D. R., Kakehasi, A. M., Pinto, M. R. D. C., & do Nascimento, M. M. G. (2021) · Revista Contexto & Saúde · doi:10.21527/2176-7114.2021.44.12356 · Cited by 3
Monitoring Social Determinants of Health Assessing Patients and Communities
Morelli, V., & Heizelman, R. (2023) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2023.04.005 · Cited by 2
Yates, W., McCluskey, P., & Wakefield, D. (2017) · Expert Review of Ophthalmology · doi:10.1080/17469899.2017.1349610 · Cited by 1
“hydroxychloroquine/CsA) (Solomon, 2011; Burska, 2015) [72].”
Dietary polyphenols: modulators of energy and substrate metabolism in obese humans
Most, J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160115jm
Cardiac Effects of Antirheumatic Drugs
Szekanecz, Z. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00020-x · Cited by 1
Cardiometabolic risk profile and body composition in early rheumatoid arthritis
Müller, R. (2020) · DSpace repository (University of Tartu)
Acne and itch: Pathogenic role of neurogenic inflammation
Sidorenko, Е. Е., Lvov, A. N., Валентиновна, М. А., Сидоренко, О. А., & Kolenko, N. G. (2022) · Medical alphabet · doi:10.33667/2078-5631-2021-9-7-11 · Cited by 1
Characterization of the crosstalk between immunity and metabolism in Drosophila melanogaster model
Davoodi, S. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-0bhx-5r30
Nieman, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737032981.793575943
Biomarkers of aging-associated chronic inflammation as a prognostic factor for human longevity
Leposavić, G., & Stojić-Vukanić, Z. (2022) · Arhiv za farmaciju · doi:10.5937/arhfarm72-36135
Randall, S. (2022) · ScholarWorks (Boise State University) · doi:10.18122/td.1950.boisestate
de Lima, G. A., Venturelli, A. C., Bello, S. R. D. B., de Souza, R. M., Pazello, C. T., Zarpellon, R. S. M., & Rodrigues, S. G. D. S. (2024) · Research Society and Development · doi:10.33448/rsd-v13i2.45052
Vicencio, Y. A., Barrera, J. P. G., Alvarado, D. A., Vargas, E. E. A., & Guillen, E. T. (2025) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v5i4.1587
Biçer, H. S., & Demirtunç, R. (2026) · Journal of Contemporary Medicine · doi:10.16899/jcm.1808008
Cytokines and insulin sensitivity
Khan, F., Akhtar, S., & Kumar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33590-7.00008-3
Yin, Z., Zhang, Y., Sun, Z., Yang, Y., Ouédraogo, S. Y., Golubnitschaja, O., Grech, G., & Zhan, X. (2026) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-032-32838-0_2
Diptimayee Upadhyay, S. R. (2026) · doi:10.52710/ijse.4227
Metadata
- Authors
- Burska, A. N., Sakthiswary, R., & Sattar, N.
- Affiliations
- University of Leeds (GB)
- University of Glasgow (GB)
- Corresponding author
- Sakthiswary, Rajalingham
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-25
- Volume
- 10
- Issue
- 6
- Pages
- e0128889
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4482317
- OpenAlex
- W1635013221
- Cited by
- 84
- References
- 40
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 14 · 2021: 12 · 2020: 10 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 7
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Greater South Information System
- Funders
- Universiti Kebangsaan Malaysia (DLP-2013-039)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- tumor necrosis factor inhibitors, rheumatoid arthritis, insulin resistance, insulin sensitivity, HOMA, QUICKI, diabetes risk
- MeSH terms
- Arthritis, Rheumatoid, Humans, Insulin Resistance, Tumor Necrosis Factor-alpha, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.